Press release
Health In Tech (Nasdaq: HIT) Surges Into 2025 With 50% Revenue Growth and Game-Changing AI Healthcare Solutions - More Stocks Inside
"We're entering 2025 with strong momentum and a clear path for scalable growth," said CEO Tim Johnson. "Our platform enhancements, new product offerings, and leadership changes position us to transform the way the healthcare insurance industry operates."
AI-Driven Innovation and Market Expansion
Health In Tech is redefining the healthcare insurance landscape through its AI-backed underwriting engine and eDIYBS platform, which simplifies the process for brokers, TPAs, and insurance carriers. The company is launching a mid-sized business underwriting solution to serve employers with over 150 employees, expanding from its traditional small business base (5-150 employees).
It also introduced a Spec & Agg stop-loss product to improve claims processing efficiency-a key enhancement for TPAs and carriers. These expansions are expected to increase the total addressable market and unlock new revenue streams.
Strategic Partnerships to Disrupt Self-Funded Healthcare
In January 2025, Health In Tech announced a breakthrough collaboration with MARPAI and Vitable DPC, combining Direct Primary Care (DPC) with comprehensive stop-loss coverage. The bundled offering, delivered through HIT's eDIYBS platform, enables cost-effective health plan quotes, empowering brokers and businesses to offer affordable, high-quality employee healthcare.
This collaboration is set to become a benchmark for operational efficiency and affordability in the self-funded health plan industry.
Q1 2025 Momentum & FY2024 Financial Highlights
* $5.7M revenue in Jan-Feb 2025, up 50% YoY
* FY2024 Revenue: $19.5 million, up 1.8%
* Cash and Equivalents: $7.8 million as of Dec. 31, 2024 (up from $2.4M YoY)
* Adjusted EBITDA: $2.3 million
* Gross Margin: 79.2%
Though year-over-year profits narrowed due to strategic investments, the company strengthened its core platform, cybersecurity, and automation capabilities-laying the foundation for long-term scalability.
IPO Milestone and Strengthened Leadership
In December 2024, Health In Tech successfully completed its Initial Public Offering (IPO), raising $9.2 million in gross proceeds. To support its growth and innovation roadmap, the company expanded its executive team:
* Chris Kurtenbach - Chief Operating Officer
* Jonathan Del Lockett - Chief Strategy Officer
* Dustin Plantholt - Chief Growth Officer
* Jenni Guerrica - Chief Information Security Officer
These appointments bring operational discipline, cybersecurity focus, and go-to-market expertise, aligning with Health In Tech's vision to be a market leader in AI-driven Insurtech solutions. With a strong start to 2025, Health In Tech plans to:
* Expand into new U.S. regional markets
* Enhance automation and AI integrations
* Continue targeting the self-funded employer market
* Deliver on its mission to eliminate complexity in healthcare insurance
"We remain committed to delivering value-driven, scalable solutions that empower brokers, TPAs, and employers to offer efficient, self-funded healthcare," Johnson added.
Other companies worth watching this week include Integrated Media Technology Limited (NASDAQ: IMTE), an emerging player in smart optics and metaverse-related technologies; Kaival Brands Innovations Group (NASDAQ: KAVL), known for distributing alternative smoking products; TEN Holdings Inc. (NASDAQ: XHLD), gaining attention for its diversified portfolio in emerging tech sectors; MicroAlgo Inc. (NASDAQ: MLGO), focused on next-gen algorithmic solutions; Windtree Therapeutics Inc. (NASDAQ: WINT), advancing treatments for acute cardiovascular diseases; and Dyadic International Inc. (NASDAQ: DYAI), a synthetic biology innovator with a proprietary protein production platform that's gaining momentum in the biotech space.
As innovation continues to drive investor interest, these companies - along with Health In Tech (NASDAQ: HIT)- are making strategic moves that could define the next wave of growth across healthcare, biotechnology, and digital transformation sectors.
Other companies worth watching this week include Integrated Media Technology Limited (NASDAQ: IMTE), an emerging player in smart optics and metaverse-related technologies; Kaival Brands Innovations Group (NASDAQ: KAVL), known for distributing alternative smoking products; TEN Holdings Inc. (NASDAQ: XHLD), gaining attention for its diversified portfolio in emerging tech sectors; MicroAlgo Inc. (NASDAQ: MLGO), focused on next-gen algorithmic solutions; Windtree Therapeutics Inc. (NASDAQ: WINT), advancing treatments for acute cardiovascular diseases; and Dyadic International Inc. (NASDAQ: DYAI), a synthetic biology innovator with a proprietary protein production platform that's gaining momentum in the biotech space.
As innovation continues to drive investor interest, these companies - along with Health In Tech (NASDAQ: HIT)- are making strategic moves that could define the next wave of growth across healthcare, biotechnology, and digital transformation sectors.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=health-in-tech-nasdaq-hit-surges-into-2025-with-50-revenue-growth-and-gamechanging-ai-healthcare-solutions-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Health In Tech (Nasdaq: HIT) Surges Into 2025 With 50% Revenue Growth and Game-Changing AI Healthcare Solutions - More Stocks Inside here
News-ID: 3933860 • Views: …
More Releases from ABNewswire
KISQALI Achieves Significant Market Growth, Strengthening Its Position in Breast …
KISQALI is a promising CDK4/6 inhibitor used in combination with aromatase inhibitors for the treatment of HR-positive, HER2-negative breast cancer. Its market potential remains strong, driven by its efficacy in prolonging progression-free survival in early and metastatic stages of the disease. With a growing demand for targeted therapies and increasing patient awareness, KISQALI's market is expected to expand further.
DelveInsight's "KISQALI Market Size, Forecast, and Market Insight Report [https://www.delveinsight.com/report-store/kisqali-ribociclib-drug-insight-market-forecast?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr]" highlights the…
TARPEYO Positioned as Market Leader in US IgA Nephropathy Therapeutics Space | D …
With a significant unmet need and limited treatment options, the TARPEYO/KINPEYGO market potential is strong, especially as it delays disease progression and reduces proteinuria. As awareness and diagnosis rates improve, uptake could accelerate, positioning TARPEYO/KINPEYGO as a leading therapy in the IgAN space.
DelveInsight's "TARPEYO/KINPEYGO Market Size, Forecast, and Market Insight Report [https://www.delveinsight.com/report-store/tarpeyo-market-drug-insight-and-market-forecast?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr]" highlights the details around TARPEYO/KINPEYGO, delayed-release capsules. The report provides product descriptions, patent details, and competitor products (marketed…
FINTEPLA's Continued Growth Offers Patients a Lifeline in the Fight Against Seve …
FINTEPLA has strong market potential due to its demonstrated efficacy in treating rare, severe epileptic syndromes like Dravet and Lennox-Gastaut, where treatment options are limited. With FDA and EMA approvals, it taps into a high-value orphan drug market. Continued global expansion and label extensions could significantly boost its commercial reach.
DelveInsight's "FINTEPLA Market Size, Forecast, and Market Insight Report [https://www.delveinsight.com/report-store/fintepla-drug-insight-and-market-forecast?utm_source=cision&utm_medium=pressrelease&utm_campaign=spr]" highlights the details around FINTEPLA, an oral medication that is a…
New Trends in Outdoor Living Led by The Deck Company of America in Nixa, MO
Outdoor living spaces have become the heart of modern homes, and Custom deck contractors [https://www.google.com/search?Custom+deck+contractors&kgmid=/g/1tfp_cfq] play a pivotal role in turning bland yards into vibrant, functional extensions of the indoors. In Nixa, MO, The Deck Company of America is setting the standard for what's possible when innovation meets craftsmanship.
Backyards Transformed by Local Expertise
Residents searching for Local Deck contractors often look for professionals who understand the area's climate, architectural style, and…
More Releases for NASDAQ:
Peraso (NASDAQ: PRSO) Pushes Back on Mobix Labs (NASDAQ: MOBX) Takeover Bid, Val …
Peraso Inc. (NASDAQ: PRSO), a leading innovator in mmWave wireless solutions, has officially acknowledged receipt of an unsolicited, non-binding acquisition proposal from Mobix Labs, Inc. (NASDAQ: MOBX). The offer proposes a stock-for-stock exchange that values Peraso at approximately $1.20 per share, representing a 20% premium over its 30-day average closing price. However, Peraso is contesting several key points made in Mobix's June 26 press release.
Financials Mischaracterized, Says Peraso
Peraso rebuffed Mobix's…
ZenaTech's (Nasdaq: ZENA) Nasdaq Listing: A Launchpad for Growth and Innovation
On October 1, ZenaTech (Nasdaq: ZENA) made its debut on the Nasdaq, a pivotal milestone for the company specializing in AI-driven drone solutions and enterprise SaaS (software-as-a-service) applications. As businesses increasingly seek innovative ways to streamline operations and boost productivity, ZenaTech stands ready to meet these demands with its advanced AI drone solutions and comprehensive software applications. Under the leadership of CEO Dr. Shaun Passley, ZenaTech aims to leverage its…
Investors Alert: EMCORE (NASDAQ: EMKR), AGBA Group (NASDAQ: AGBA), Peraso Inc. ( …
EMCORE Corporation (NASDAQ: EMKR) saw its shares soar today following a major announcement from Mobix Labs (NASDAQ: MOBX). Mobix Labs, a leader in advanced wireless solutions for military and defense, has submitted a proposal to acquire all outstanding shares of EMCORE for $3.80 per share in cash, positioning itself as a key player in the aerospace and defense sectors. This move could provide immediate value to shareholders, making it an…
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO) …
Pre-market trading is heating up as Black Diamond Therapeutics, Inc. (Nasdaq: BDTX) surges on positive Phase 2 data for its cancer treatment BDTX-1535. Peraso Inc. (NASDAQ: PRSO) continues its expansion into the Asian markets and a major military contract. Kaival Brands (NASDAQ: KAVL) saw its stock surge in early trading today on merger announcement. Other stocks to watch include Banzai International Inc. (NASDAQ: BNZI), which saw a 97.51% rally after…
Lawsuit filed for Investors who lost money with Alphabet Inc. (NASDAQ: GOOG, NAS …
An investor, who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), filed a lawsuit over alleged violations of Federal Securities Laws by Alphabet Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Alphabet Inc. (NASDAQ: GOOG, NASDAQ: GOOGL), have certain options and for certain investors are short and strict deadlines running. Deadline: May 15, 2023. NASDAQ: GOOG, NASDAQ: GOOGL investors should contact the Shareholders…
Investigation announced for Investors in NASDAQ: MTTR over possible Wrongdoing a …
An investigation was announced for investors in shares of Matterport, Inc. (NASDAQ: MTTR) was announced over potential breaches of fiduciary duties by certain officers and directors at Matterport, Inc.
Investors who purchased shares of Matterport, Inc. (NASDAQ: MTTR) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Matterport, Inc. directors breached their fiduciary duties and…
